Qorvo, Inc. (QRVO) director Walden Rhines granted 2,327 common shares

Rhea-AI Filing Summary

Qorvo, Inc. director Walden C. Rhines reported a compensation-related acquisition of 2,327 shares of common stock on August 12, 2026. The shares were acquired at a stated price of $0.00 per share, increasing his directly held position to 74,065 shares of Qorvo common stock.

Insider Trade Summary

Net Buyer: 2,327 shares

Net Buy 1 txn

Insider RHINES WALDEN C

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,327	$0.00	$0.00

Holdings After Transaction: Common Stock — 74,065 shares (Direct)

Key Figures

Shares granted: 2,327 shares Price per share: $0.00 per share Shares held after transaction: 74,065 shares

3 metrics

Shares granted 2,327 shares Non-derivative grant or award on August 12, 2026

Price per share $0.00 per share Reported transaction price for the 2,327-share award

Shares held after transaction 74,065 shares Direct holdings of Walden C. Rhines following the grant

Key Terms

Form 4, non-derivative, grant or award acquisition

3 terms

Form 4 regulatory

"The Qorvo Form 4 shows only a single acquisition transaction coded "A""

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

non-derivative financial

"It represents a non-derivative compensation-related award of 2,327 Qorvo common shares"

grant or award acquisition financial

"The transaction was a grant or award acquisition, coded "A" on the Form 4"

FAQ

What insider transaction did Qorvo (QRVO) report for Walden C. Rhines?

Qorvo reported that director Walden C. Rhines received a grant or award of 2,327 shares of Qorvo common stock on August 12, 2026 as a non-derivative acquisition.

How many Qorvo (QRVO) shares did Walden C. Rhines hold after this Form 4 transaction?

After the reported transaction, Walden C. Rhines directly held 74,065 shares of Qorvo common stock. This reflects his position immediately following the 2,327-share grant or award on August 12, 2026.

Was the Qorvo (QRVO) Form 4 transaction by Walden C. Rhines a purchase or a grant?

The transaction was a grant or award acquisition, coded "A" on the Form 4. It represents a non-derivative compensation-related award of 2,327 Qorvo common shares rather than an open-market purchase.

What price per share is reported for Walden C. Rhines’ Qorvo (QRVO) stock award?

The Form 4 reports a transaction price of $0.00 per share for the 2,327-share grant. This is consistent with a stock award provided as compensation, not a cash purchase in the market.

Does the Qorvo (QRVO) Form 4 indicate any stock sales by Walden C. Rhines?

No stock sales are reported. The Form 4 shows only a single acquisition transaction coded "A" for 2,327 shares, increasing Walden C. Rhines’ direct holdings to 74,065 Qorvo common shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 08/13/2026 - 05:04 PM Accepted by SEC EDGAR 08/13/2026 - 05:04 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RHINES WALDEN C

(Last) (First) (Middle)

C/O QORVO, INC.

7628 THORNDIKE ROAD

(Street)

GREENSBORO NORTH CAROLINA 27409

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Qorvo, Inc. [ QRVO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/12/2026		A		2,327	A	$0	74,065	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Jason T. Gray, by Power of Attorney	08/13/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)